Advances of exosomes in diabetic wound healing

Abstract

Poor wound healing is a refractory process that places an enormous medical and financial burden on diabetic patients. Exosomes have recently been recognized as crucial players in the healing of diabetic lesions. They have excellent stability, homing effects, biocompatibility, and reduced immunogenicity as novel cell-free therapies. In addition to transporting cargos to target cells to enhance intercellular communication, exosomes are beneficial in nearly every phase of diabetic wound healing. They participate in modulating the inflammatory response, accelerating proliferation and reepithelialization, increasing angiogenesis, and regulating extracellular matrix remodeling. Accumulating evidence indicates that hydrogels or dressings in conjunction with exosomes can prolong the duration of exosome residency in diabetic wounds. This review provides an overview of the mechanisms, delivery, clinical application, engineering, and existing challenges of the use of exosomes in diabetic wound repair. We also propose future directions for biomaterials incorporating exosomes: 2D or 3D scaffolds, biomaterials loaded with wound healing-promoting gases, intelligent biomaterials, and the prospect of systematic application of exosomes. These findings may might shed light on future treatments and enlighten some studies to improve quality of life among diabetes patients.

References

[1] Bai Q, Han K, Dong K, Zheng C, Zhang Y, Long Q, et al. Potential applications of nanomaterials and Technology for Diabetic Wound Healing. Int J Nanomedicine. 2020; 15: 9717-43. https://doi.org/10.2147/IJN.S276001.

[2] Vijayakumar V, Samal SK, Mohanty S, Nayak SK Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management. Int J Biol Macromol. 2019; 122: 137-48. https://doi.org/10.1016/j.ijbiomac.2018.10.120.

[3] Armstrong DG, Tan TW, Boulton AJM, Bus SA Diabetic foot ulcers: a review. JAMA. 2023; 330: 62-75. https://doi.org/10.1001/jama.2023.10578.

[4] An Y, Lin S, Tan X, Zhu S, Nie F, Zhen Y, et al. Exosomes from adipose-derived stem cells and application to skin wound healing. Cell Prolif. 2021; 54: e12993. https://doi.org/10.1111/cpr.12993.

[5] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367: eaau6977. https://doi.org/10.1126/science.aau6977.

[6] Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell. 2019; 177: 428-445.e18. https://doi.org/10.1016/j.cell.2019.02.029.

[7] Zhang Y, Liu Y, Liu H, Tang WH Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9: 19. https://doi.org/10.1186/s13578-019-0282-2.

[8] Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, et al. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther. 2021; 12: 297. https://doi.org/10.1186/s13287-021-02378-7.

[9] Vu NB, Nguyen HT, Palumbo R, Pellicano R, Fagoonee S, Pham PV Stem cell-derived exosomes for wound healing: current status and promising directions. Minerva Med. 2021; 112: 384-400. https://doi.org/10.23736/S0026-4806.20.07205-5.

[10] Bian D, Wu Y, Song G, Azizi R, Zamani A The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review. Stem Cell Res Ther. 2022; 13: 24. https://doi.org/10.1186/s13287-021-02697-9.

[11] Mengdi Z, Ke J, Liang G, Zhengkui Z, Fang L, Fangfang Z, et al. Methods and Technologies for Exosome Isolation and Characterization. Small Methods. 2018; 2: 1800021. https://doi.org/10.1002/smtd.201800021.

[12] Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017; 120: 1632-48. https://doi.org/10.1161/CIRCRESAHA.117.309417.

[13] Hade MD, Suire CN, Suo Z. Mesenchymal stem cell-derived exosomes: applications in regenerative medicine. Cells. 2021; 10: 1959. https://doi.org/10.3390/cells10081959.

[14] Pomatto M, Gai C, Negro F, Cedrino M, Grange C, Ceccotti E, et al. Differential therapeutic effect of extracellular vesicles derived by bone marrow and adipose mesenchymal stem cells on wound healing of diabetic ulcers and correlation to their cargoes. Int J Mol Sci. 2021; 22: 3851. https://doi.org/10.3390/ijms22083851.

[15] Hoang DH, Nguyen TD, Nguyen HP, Nguyen XH, Do PTX, Dang VD, et al. Differential wound healing capacity of mesenchymal stem cell-derived exosomes originated from bone marrow, adipose tissue and umbilical cord under serum-and Xeno-free condition. Front Mol Biosci. 2020; 7: 119. https://doi.org/10.3389/fmolb.2020.00119.

[16] Yates CC, Rodrigues M, Nuschke A, Johnson ZI, Whaley D, Stolz D, et al. Multipotent stromal cells/mesenchymal stem cells and fibroblasts combine to minimize skin hypertrophic scarring. Stem Cell Res Ther. 2017; 8: 193. https://doi.org/10.1186/s13287-017-0644-9.

[17] Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009; 5: 54-63. https://doi.org/10.1016/j.stem.2009.05.003.

[18] Perlee D, van Vught LA, Scicluna BP, Maag A, Lutter R, Kemper EM, et al. Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial. Stem Cells Dayt Ohio. 2018; 36: 1778-88. https://doi.org/10.1002/stem.2891.

[19] Yang J, Dai C, Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J Am Soc Nephrol JASN. 2005; 16: 68-78. https://doi.org/10.1681/ASN.2003090795.

[20] Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015; 17: 11-22. https://doi.org/10.1016/j.stem.2015.06.007.

[21] Guillamat-Prats R. The role of MSC in wound healing. Scarring and Regeneration Cells. 2021; 10: 1729. https://doi.org/10.3390/cells10071729.

[22] Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X, et al. Exosomes, a new star for targeted delivery. Front Cell Dev Biol. 2021; 9: 751079. https://doi.org/10.3389/fcell.2021.751079.

[23] Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br J Dermatol. 2015; 173: 370-8. https://doi.org/10.1111/bjd.13954.

[24] Pugliese E, Coentro JQ, Raghunath M, Zeugolis DI Wound healing and scar wars. Adv Drug Deliv Rev. 2018; 129: 1-3. https://doi.org/10.1016/j.addr.2018.05.010.

[25] Broughton G, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg. 2006; 117: 1e-S-32e-S. https://doi.org/10.1097/01.prs.0000222562.60260.f9.

[26] Hesketh M, Sahin KB, West ZE, Murray RZ Macrophage phenotypes regulate scar formation and chronic wound healing. Int J Mol Sci. 2017; 18: 1545. https://doi.org/10.3390/ijms18071545.

[27] Pastar I, Stojadinovic O, Yin NC, Ramirez H, Nusbaum AG, Sawaya A, et al. Epithelialization in wound healing: a comprehensive review. Adv Wound Care. 2014; 3: 445-64. https://doi.org/10.1089/wound.2013.0473.

[28] Venugopal H, Hanna A, Humeres C, Frangogiannis NG Properties and functions of fibroblasts and Myofibroblasts in myocardial infarction. Cells. 2022; 11: 1386. https://doi.org/10.3390/cells11091386.

[29] Hade MD, Suire CN, Mossell J, Suo Z Extracellular vesicles: emerging frontiers in wound healing. Med Res Rev. 2022; 42: 2102-25. https://doi.org/10.1002/med.21918.

[30] Singh S. The physiology of wound healing. Surgery. 2017; 35: 473, 7. https://doi.org/10.1016/j.mpsur.2017.06.004.

[31] Falanga V. Wound healing and its impairment in the diabetic foot. Lancet Lond Engl. 2005; 366: 1736-43. https://doi.org/10.1016/S0140-6736(05)67700-8.

[32] Joorabloo A, Liu T. Engineering exosome-based biomimetic nanovehicles for wound healing. J Control Release Off J Control Release Soc. 2023; 356: 463-80. https://doi.org/10.1016/j.jconrel.2023.03.013.

[33] Falanga V CHRONIC WOUNDS. Nat Rev Dis Primers. 2022; 8. https://doi.org/10.1038/s41572-022-00377-3.

[34] Li D, Wu N. Mechanism and application of exosomes in the wound healing process in diabetes mellitus. Diabetes Res Clin Pract. 2022; 187: 109882. https://doi.org/10.1016/j.diabres.2022.109882.

[35] Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PIH Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016; 473: 4527-50. https://doi.org/10.1042/BCJ20160503C.

[36] Shen J, Zhao X, Zhong Y, Yang P, Gao P, Wu X, et al. Exosomal ncRNAs: the pivotal players in diabetic wound healing. Front Immunol. 2022; 13: 1005307. https://doi.org/10.3389/fimmu.2022.1005307.

[37] Basu Mallik S, Jayashree BS, Shenoy RR. Epigenetic modulation of macrophage polarization-perspectives in diabetic wounds. J Diabetes Complicat. 2018; 32: 524-30. https://doi.org/10.1016/j.jdiacomp.2018.01.015.

[38] Lou R, Chen J, Zhou F, Wang C, Leung CH, Lin L Exosome-cargoed microRNAs: potential therapeutic molecules for diabetic wound healing. Drug Discov Today. 2022; 27: 103323. https://doi.org/10.1016/j.drudis.2022.07.008.

[39] Patel S, Srivastava S, Singh MR, Singh D Mechanistic insight into diabetic wounds: pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother. 2019; 112: 108615. https://doi.org/10.1016/j.biopha.2019.108615.

[40] Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. Ingelfinger JR, editor. N Engl J Med. 2017; 376: 2367-75. https://doi.org/10.1056/NEJMra1615439.

[41] Lin CM, Wang BW, Pan CM, Fang WJ, Chua SK, Cheng WP, et al. Chrysin boosts KLF2 expression through suppression of endothelial cell-derived exosomal microRNA-92a in the model of atheroprotection. Eur J Nutr. 2021; 60: 4345-55. https://doi.org/10.1007/s00394-021-02593-1.

[42] Tong X, Dang X, Liu D, Wang N, Li M, Han J, et al. Exosome-derived circ_0001785 delays atherogenesis through the ceRNA network mechanism of miR-513a-5p/TGFBR3. J Nanobiotechnology. 2023; 21: 362. https://doi.org/10.1186/s12951-023-02076-x.

[43] Yang Q, Su S, Liu S, Yang S, Xu J, Zhong Y, et al. Exosomes-loaded electroconductive nerve dressing for nerve regeneration and pain relief against diabetic peripheral nerve injury. Bioact Mater. 2023; 26: 194-215. https://doi.org/10.1016/j.bioactmat.2023.02.024.

[44] Liu X, Wu C, Zhang Y, Chen S, Ding J, Chen Z, et al. Hyaluronan-based hydrogel integrating exosomes for traumatic brain injury repair by promoting angiogenesis and neurogenesis. Carbohydr Polym. 2023; 306: 120578. https://doi.org/10.1016/j.carbpol.2023.120578.

[45] Sinno H, Prakash S. Complements and the wound healing cascade: an updated review. Plast Surg Int. 2013; 2013: 1-7. https://doi.org/10.1155/2013/146764.

[46] Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci CMLS. 2016; 73: 3861-85. https://doi.org/10.1007/s00018-016-2268-0.

[47] Mustoe TA, O’Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg. 2006; 117: 35S-41. https://doi.org/10.1097/01.prs.0000225431.63010.1b.

[48] Zhang Y, Bai X, Shen K, Luo L, Zhao M, Xu C, et al. Exosomes derived from adipose mesenchymal stem cells promote diabetic chronic wound healing through SIRT3/SOD2. Cells. 2022; 11: 2568. https://doi.org/10.3390/cells11162568.

[49] Dalirfardouei R, Jamialahmadi K, Jafarian AH, Mahdipour E Promising effects of exosomes isolated from menstrual blood-derived mesenchymal stem cell on wound-healing process in diabetic mouse model. J Tissue Eng Regen Med. 2019; 13: 555-68. https://doi.org/10.1002/term.2799.

[50] Wang P, Theocharidis G, Vlachos IS, Kounas K, Lobao A, Shu B, et al. Exosomes derived from epidermal stem cells improve diabetic wound healing. J Invest Dermatol. 2022; 142: 2508-2517.e13. https://doi.org/10.1016/j.jid.2022.01.030.

[51] Li M, Wang T, Tian H, Wei G, Zhao L, Shi Y Macrophage-derived exosomes accelerate wound healing through their anti-inflammation effects in a diabetic rat model. Artif Cells Nanomedicine Biotechnol. 2019; 47: 3793-803. https://doi.org/10.1080/21691401.2019.1669617.

[52] Geiger A, Walker A, Nissen E.Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice. Biochem Biophys Res Commun. 2015; 467: 303-9. https://doi.org/10.1016/j.bbrc.2015.09.166.

[53] Liao Q, Su L, Pang L, Li J, Li H, Li J, et al. Natural exosome-like nanoparticles derived from ancient medicinal insect Periplaneta americana L. as a novel diabetic wound healing accelerator. J Nanobiotechnology. 2023; 21: 169. https://doi.org/10.1186/s12951-023-01923-1.

[54] Li B, Luan S, Chen J, Zhou Y, Wang T, Li Z, et al. The MSC-derived Exosomal lncRNA H19 promotes wound healing in diabetic foot ulcers by upregulating PTEN via MicroRNA-152-3p. Mol Ther Nucleic Acids. 2020; 19: 814-26. https://doi.org/10.1016/j.omtn.2019.11.034.

[55] Gondaliya P, Sayyed AA, Bhat P, Mali M, Arya N, Khairnar A, et al. Mesenchymal stem cell-derived exosomes loaded with miR-155 inhibitor ameliorate diabetic wound healing. Mol Pharm. 2022; 19: 1294-308. https://doi.org/10.1021/acs.molpharmaceut.1c00669.

[56] Ren S, Chen J, Guo J, Liu Y, Xiong H, Jing B, et al. Exosomes from adipose stem cells promote diabetic wound healing through the eHSP90/LRP1/AKT Axis. Cells. 2022; 11: 3229. https://doi.org/10.3390/cells11203229.

[57] Hsu HH, Wang AYL, Loh CYY, Pai AA, Kao HK Therapeutic potential of exosomes derived from diabetic adipose stem cells in cutaneous wound healing of db/db mice. Pharmaceutics. 2022; 14: 1206. https://doi.org/10.3390/pharmaceutics14061206.

[58] Yu P, Guo J, Li J, Shi X, Xu N, Jiang Y, et al. lncRNA-H19 in fibroblasts promotes wound healing in diabetes. Diabetes. 2022; 71: 1562-78. https://doi.org/10.2337/db21-0724.

[59] Hu SC-S, Lan C-CE. High-glucose environment disturbs the physiologic functions of keratinocytes: focusing on diabetic wound healing. J Dermatol Sci. 2016; 84: 121-7. https://doi.org/10.1016/j.jdermsci.2016.07.008.

[60] Li X, Xie X, Lian W, Shi R, Han S, Zhang H, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol.

[61] Zhang W, Wang L, Guo H, Chen L, Huang X Dapagliflozin-loaded exosome Mimetics facilitate diabetic wound healing by HIF-1α-mediated enhancement of angiogenesis. Adv Healthc Mater. 2023; 12: e2202751. https://doi.org/10.1002/adhm.202202751.

[62] Wang Y, Cao Z, Wei Q, Ma K, Hu W, Huang Q, et al. VH298-loaded extracellular vesicles released from gelatin methacryloyl hydrogel facilitate diabetic wound healing by HIF-1α-mediated enhancement of angiogenesis. Acta Biomater. 2022; 147: 342-55. https://doi.org/10.1016/j.actbio.2022.05.018.

[63] Han ZF, Cao JH, Liu ZY, Yang Z, Qi RX, Xu HL Exosomal lncRNA KLF3-AS1 derived from bone marrow mesenchymal stem cells stimulates angiogenesis to promote diabetic cutaneous wound healing. Diabetes Res Clin Pract. 2022; 183: 109126. https://doi.org/10.1016/j.diabres.2021.109126.

[64] Chen CY, Rao SS, Ren L, Hu XK, Tan YJ, Hu Y, et al. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics. 2018; 8: 1607-23. https://doi.org/10.7150/thno.22958.

[65] Yan C, Xv Y, Lin Z, Endo Y, Xue H, Hu Y, et al. Human umbilical cord mesenchymal stem cell-derived exosomes accelerate diabetic wound healing via ameliorating oxidative stress and promoting angiogenesis. Front Bioeng Biotechnol. 2022; 10: 829868. https://doi.org/10.3389/fbioe.2022.829868.

[66] Yu Q, Liu L, Zhang X, Chang H, Ma S, Xie Z, et al. MiR-221-3p targets HIPK2 to promote diabetic wound healing. Microvasc Res. 2022; 140: 104306. https://doi.org/10.1016/j.mvr.2021.104306.

[67] Fu W, Liang D, Wu X, Chen H, Hong X, Wang J, et al. Long noncoding RNA LINC01435 impedes diabetic wound healing by facilitating YY1-mediated HDAC8 expression. iScience. 2022; 25: 104006. https://doi.org/10.1016/j.isci.2022.104006.

[68] Yan C, Chen J, Wang C, Yuan M, Kang Y, Wu Z, et al. Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis. Drug Deliv. 2022; 29:214-28. https://doi.org/10.1080/10717544.2021.2023699.

[69] Xiang X, Chen J, Jiang T, Yan C, Kang Y, Zhang M, et al. Milk-derived exosomes carrying siRNA-KEAP1 promote diabetic wound healing by improving oxidative stress. Drug Deliv Transl Res. 2023; 13: 2286-96. https://doi.org/10.1007/s13346-023-01306-x.

[70] Chen L, Qin L, Chen C, Hu Q, Wang J, Shen J Serum exosomes accelerate diabetic wound healing by promoting angiogenesis and ECM formation. Cell Biol Int. 2021; 45: 1976-85. https://doi.org/10.1002/cbin.11627.

[71] Xiong Y, Chen L, Yu T, Yan C, Zhou W, Cao F, et al. Inhibition of circulating exosomal microRNA-15a-3p accelerates diabetic wound repair. Aging. 2020; 12: 8968-86. https://doi.org/10.18632/aging.103143.

[72] Zhao B, Zhang X, Zhang Y, Lu Y, Zhang W, Lu S, et al. Human exosomes accelerate cutaneous wound healing by promoting collagen synthesis in a diabetic mouse model. Stem Cells Dev. 2021; 30: 922-33. https://doi.org/10.1089/scd.2021.0100.

[73] Chang M, Nguyen TT. Strategy for treatment of infected diabetic foot ulcers. Acc Chem Res. 2021; 54: 1080-93. https://doi.org/10.1021/acs.accounts.0c00864.

[74] Dong J, Wu B, Tian W. How to maximize the therapeutic effect of exosomes on skin wounds in diabetes mellitus: review and discussion. Front Endocrinol. 2023; 14: 1146991. https://doi.org/10.3389/fendo.2023.1146991.

[75] Liu L, Liu D. Bioengineered mesenchymal stem cell-derived exosomes: emerging strategies for diabetic wound healing. Burns Trauma. 2024; 12. https://doi.org/10.1093/burnst/tkae030.

[76] Chaudhari A, Vig K, Baganizi D, Sahu R, Dixit S, Dennis V, et al. Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review. Int J Mol Sci. 2016; 17: 1974. https://doi.org/10.3390/ijms17121974.

[77] Safari B, Aghazadeh M, Davaran S, Roshangar L Exosome-loaded hydrogels: a new cell-free therapeutic approach for skin regeneration. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2022; 171: 50-9. https://doi.org/10.1016/j.ejpb.2021.11.002.

[78] Wang C, Wang M, Xu T, Zhang X, Lin C, Gao W, et al. Engineering bioactive self-healing antibacterial exosomes hydrogel for promoting chronic diabetic wound healing and complete skin regeneration. Theranostics. 2019; 9: 65-76. https://doi.org/10.7150/thno.29766.

[79] Akbari A, Jabbari N, Sharifi R, Ahmadi M, Vahhabi A, Seyedzadeh SJ, et al. Free and hydrogel encapsulated exosome-based therapies in regenerative medicine. Life Sci. 2020; 249: 117447. https://doi.org/10.1016/j.lfs.2020.117447.

[80] Riau AK, Ong HS, Yam GHF, Mehta JS Sustained delivery system for stem cell-derived exosomes. Front Pharmacol. 2019; 10: 1368. https://doi.org/10.3389/fphar.2019.01368.

[81] Xiong Y, Chen L, Liu P, Yu T, Lin C, Yan C, et al. All-in-one: multifunctional hydrogel accelerates oxidative diabetic wound healing through timed-release of exosome and fibroblast growth factor. Small. 2022; 18: e2104229. https://doi.org/10.1002/smll.202104229.

[82] Wang M, Wang C, Chen M, Xi Y, Cheng W, Mao C, et al. Efficient angiogenesis-based diabetic wound healing/skin reconstruction through bioactive antibacterial adhesive ultraviolet shielding Nanodressing with exosome release. ACS Nano. 2019; 13: 10279-93. https://doi.org/10.1021/acsnano.9b03656.

[83] Jiang T, Liu S, Wu Z, Li Q, Ren S, Chen J, et al. ADSC-exo@MMP-PEG smart hydrogel promotes diabetic wound healing by optimizing cellular functions and relieving oxidative stress. Mater Today Bio. 2022; 16: 100365. https://doi.org/10.1016/j.mtbio.2022.100365.

[84] Shafei S, Khanmohammadi M, Heidari R, Ghanbari H, Taghdiri Nooshabadi V, Farzamfar S, et al. Exosome loaded alginate hydrogel promotes tissue regeneration in full-thickness skin wounds: An in vivo study. J Biomed Mater Res A. 2020; 108: 545-56. https://doi.org/10.1002/jbm.a.36835.

[85] Hu N, Cai Z, Jiang X, Wang C, Tang T, Xu T, et al. Hypoxia-pretreated ADSC-derived exosome-embedded hydrogels promote angiogenesis and accelerate diabetic wound healing. Acta Biomater. 2023; 157: 175-86. https://doi.org/10.1016/j.actbio.2022.11.057.

[86] Yang J, Chen Z, Pan D, Li H, Shen J Umbilical cord-derived mesenchymal stem cell-derived exosomes combined Pluronic F127 hydrogel promote chronic diabetic wound healing and complete skin regeneration. Int J Nanomedicine. 2020; 15: 5911-26. https://doi.org/10.2147/IJN.S249129.

[87] Zhang Y, Zhang P, Gao X, Chang L, Chen Z, Mei X Preparation of exosomes encapsulated nanohydrogel for accelerating wound healing of diabetic rats by promoting angiogenesis. Mater Sci Eng C. 2021; 120: 111671. https://doi.org/10.1016/j.msec.2020.111671.

[88] Zhang X, Gan J, Fan L, Luo Z, Zhao Y Bioinspired adaptable indwelling microneedles for treatment of diabetic ulcers. Adv Mater. 2023; 35: e2210903. https://doi.org/10.1002/adma.202210903.

[89] Zhang Y, Li M, Wang Y, Han F, Shen K, Luo L, et al. Exosome/metformin-loaded self-healing conductive hydrogel rescues microvascular dysfunction and promotes chronic diabetic wound healing by inhibiting mitochondrial fission. Bioact Mater. 2023; 26: 323-36. https://doi.org/10.1016/j.bioactmat.2023.01.020.

[90] Wang Y, Song P, Wu L, Su Z, Gui X, Gao C, et al. In situ photocrosslinked adhesive hydrogel loaded with mesenchymal stem cell-derived extracellular vesicles promotes diabetic wound healing. J Mater Chem B. 2023; 11: 837-51. https://doi.org/10.1039/D2TB02371G.

[91] Yuan M, Liu K, Jiang T, Li S, Chen J, Wu Z, et al. GelMA/PEGDA microneedles patch loaded with HUVECs-derived exosomes and Tazarotene promote diabetic wound healing. J Nanobiotechnology. 2022; 20: 147. https://doi.org/10.1186/s12951-022-01354-4.

[92] Yu Y, Jin H, Li L, Zhang X, Zheng C, Gao X, et al. An injectable, activated neutrophil-derived exosome mimetics/extracellular matrix hybrid hydrogel with antibacterial activity and wound healing promotion effect for diabetic wound therapy. J Nanobiotechnology. 2023; 21: 308. https://doi.org/10.1186/s12951-023-02073-0.

[93] Shiekh PA, Singh A, Kumar A. Exosome laden oxygen releasing antioxidant and antibacterial cryogel wound dressing OxOBand alleviate diabetic and infectious wound healing. Biomaterials. 2020; 249: 120020. https://doi.org/10.1016/j.biomaterials.2020.120020.

[94] Xiao S, Xiao C, Miao Y, Wang J, Chen R, Fan Z, et al. Human acellular amniotic membrane incorporating exosomes from adipose-derived mesenchymal stem cells promotes diabetic wound healing. Stem Cell Res Ther. 2021; 12: 255. https://doi.org/10.1186/s13287-021-02333-6.

[95] Zhang Y, Fang M, Xie W, Zhang YA, Jiang C, Li N, et al. Sprayable alginate hydrogel dressings with oxygen production and exosome loading for the treatment of diabetic wounds. Int J Biol Macromol. 2023; 242: 125081. https://doi.org/10.1016/j.ijbiomac.2023.125081.

[96] Zeng J, Sun Z, Zeng F, Gu C, Chen X. M2 macrophage-derived exosome-encapsulated microneedles with mild photothermal therapy for accelerated diabetic wound healing. Mater Today Bio. 2023; 20: 100649. https://doi.org/10.1016/j.mtbio.2023.100649.

[97] Bakadia BM, Qaed Ahmed AA, Lamboni L, Shi Z, Mutu Mukole B, Zheng R, et al. Engineering homologous platelet-rich plasma, platelet-rich plasma-derived exosomes, and mesenchymal stem cell-derived exosomes-based dual-crosslinked hydrogels as bioactive diabetic wound dressings. Bioact Mater. 2023; 28: 74-94. https://doi.org/10.1016/j.bioactmat.2023.05.002.

[98] Martin KE, Hunckler MD, Chee E, Caplin JD, Barber GF, Kalelkar PP, et al. Hydrolytic hydrogels tune mesenchymal stem cell persistence and immunomodulation for enhanced diabetic cutaneous wound healing. Biomaterials. 2023; 301: 122256. https://doi.org/10.1016/j.biomaterials.2023.122256.

[99] Du F, Liu M, Wang J, Hu L, Zeng D, Zhou S, et al. Metformin coordinates with mesenchymal cells to promote VEGF-mediated angiogenesis in diabetic wound healing through Akt/mTOR activation. Metabolism. 2023; 140: 155398. https://doi.org/10.1016/j.metabol.2023.155398.

[100] Wu YY, Jiao YP, Xiao LL, Li MM, Liu HW, Li SH, et al. Experimental study on effects of adipose-derived stem cell-seeded silk fibroin chitosan film on wound healing of a diabetic rat model. Ann Plast Surg. 2018; 80: 572-80. https://doi.org/10.1097/SAP.0000000000001355.

[101] Sun L, Li J, Gao W, Shi M, Tang F, Fu X, et al. Coaxial nanofibrous scaffolds mimicking the extracellular matrix transition in the wound healing process promoting skin regeneration through enhancing immunomodulation. J Mater Chem B. 2021; 9: 1395-405. https://doi.org/10.1039/D0TB01933J.

[102] Li J, Zhang T, Pan M, Xue F, Lv F, Ke Q, et al. Nanofiber/hydrogel core-shell scaffolds with three-dimensional multilayer patterned structure for accelerating diabetic wound healing. J Nanobiotechnology. 2022; 20: 28. https://doi.org/10.1186/s12951-021-01208-5.

[103] Jeong GJ, Im GB, Lee TJ, Kim SW, Jeon HR, Lee DH, et al. Development of a stem cell spheroid-laden patch with high retention at skin wound site. Bioeng Transl Med. 2022; 7: e10279. https://doi.org/10.1002/btm2.10279.

[104] Chen S, Wang H, Su Y, John JV, McCarthy A, Wong SL, et al. Mesenchymal stem cell-laden, personalized 3D scaffolds with controlled structure and fiber alignment promote diabetic wound healing. Acta Biomater. 2020; 108: 153-67. https://doi.org/10.1016/j.actbio.2020.03.035.

[105] Ferroni L, D’Amora U, Gardin C, Leo S, Dalla Paola L, Tremoli E, et al. Stem cell-derived small extracellular vesicles embedded into methacrylated hyaluronic acid wound dressings accelerate wound repair in a pressure model of diabetic ulcer. J Nanobiotechnology. 2023; 21: 469. https://doi.org/10.1186/s12951-023-02202-9.

[106] Jiang X, Ma J, Xue K, Chen J, Zhang Y, Zhang G, et al. Highly bioactive MXene-M2-exosome nanocomposites promote Angiogenic diabetic wound repair through reconstructing high glucose-derived immune inhibition. ACS Nano. 2024; 18: 4269-86. https://doi.org/10.1021/acsnano.3c09721.

[107] Ben-Yehuda Greenwald M, Liu YH, Li W, Hiebert P, Zubair M, Tenor H, et al. Topical wound treatment with a nitric oxide-releasing PDE5 inhibitor formulation enhances blood perfusion and promotes healing in mice. Pharmaceutics. 2022; 14: 2358. https://doi.org/10.3390/pharmaceutics14112358.

[108] Rizk M, Witte MB, Barbul A. Nitric oxide and wound healing. World J Surg. 2004; 28: 301-6. https://doi.org/10.1007/s00268-003-7396-7.

[109] Malone-Povolny MJ, Maloney SE, Schoenfisch MH. Nitric oxide therapy for diabetic wound healing. Adv Healthc Mater. 2019; 8: e1801210. https://doi.org/10.1002/adhm.201801210.

[110] Luo J, Chen AF. Nitric oxide: a newly discovered function on wound healing.Acta Pharmacol Sin. 2005; 26: 259-64. https://doi.org/10.1111/j.1745-7254.2005.00058.x.

[111] Man MQ, Wakefield JS, Mauro TM, Elias PM Role of nitric oxide in regulating epidermal permeability barrier function. Exp Dermatol. 2022; 31: 290-8. https://doi.org/10.1111/exd.14470.

[112] Nie X, Zhang H, Shi X, Zhao J, Chen Y, Wu F, et al. Asiaticoside nitric oxide gel accelerates diabetic cutaneous ulcers healing by activating Wnt/β-catenin signaling pathway. Int Immunopharmacol. 2020; 79: 106109. https://doi.org/10.1016/j.intimp.2019.106109.

[113] Liu Y, Zhao J, Mu X, Deng J, Wu X, He W, et al. Asiaticoside-nitric oxide promoting diabetic wound healing through the miRNA-21-5p/TGF-β1/SMAD7/TIMP3 signaling pathway. J Ethnopharmacol. 2024; 319: 117266. https://doi.org/10.1016/j.jep.2023.117266.

[114] He M, Sun L, Fu X, McDonough SP, Chu CC Biodegradable amino acid-based poly(ester amine) with tunable immunomodulating properties and their in vitro and in vivo wound healing studies in diabetic rats’ wounds. Acta Biomater. 2019; 84: 114-32. https://doi.org/10.1016/j.actbio.2018.11.053.

[115] Zhao Y, Luo L, Huang L, Zhang Y, Tong M, Pan H, et al. In situ hydrogel capturing nitric oxide microbubbles accelerates the healing of diabetic foot. J Control Release Off J Control Release Soc. 2022; 350: 93-106. https://doi.org/10.1016/j.jconrel.2022.08.018.

[116] Sivaraj D, Noishiki C, Kosaric N, Kiwanuka H, Kussie HC, Henn D, et al. Nitric oxide-releasing gel accelerates healing in a diabetic murine splinted excisional wound model. Front Med. 2023; 10: 1060758. https://doi.org/10.3389/fmed.2023.1060758.

[117] Ali IH, Khalil IA, Hefnawy A, Chester A, Yacoub MH, El-Sherbiny IM Exogenous and endogenous nitric oxide eluting polylactic acid-based nanofibrous scaffolds for enhancing angiogenesis of diabetic wounds. Int J Biol Macromol. 2024; 261: 129736. https://doi.org/10.1016/j.ijbiomac.2024.129736.

[118] Huang Q, Yang Z, Tao X, Ma C, Cao P, Wei P, et al. Sprayable chitosan nanogel with nitric oxide to accelerate diabetic wound healing through bacteria inhibition, biofilm eradication and macrophage polarization. Int J Biol Macromol. 2024; 254: 127806. https://doi.org/10.1016/j.ijbiomac.2023.127806.

[119] Tu C, Lu H, Zhou T, Zhang W, Deng L, Cao W, et al. Promoting the healing of infected diabetic wound by an anti-bacterial and nano-enzyme-containing hydrogel with inflammation-suppressing, ROS-scavenging, oxygen and nitric oxide-generating properties. Biomaterials. 2022; 286: 121597. https://doi.org/10.1016/j.biomaterials.2022.121597.

[120] Zhou X, Wang H, Zhang J, Li X, Wu Y, Wei Y, et al. Functional poly(ε-caprolactone)/chitosan dressings with nitric oxide-releasing property improve wound healing. Acta Biomater. 2017; 54: 128-37. https://doi.org/10.1016/j.actbio.2017.03.011.

[121] Razmjooee K, Oustadi F, Golaghaei A, Nassireslami E Carboxymethyl chitosan-alginate hydrogel containing GSNO with the ability to nitric oxide release for diabetic wound healing. Biomed Mater Bristol Engl. 2022; 17: 055013. https://doi.org/10.1088/1748-605X/ac877c.

[122] Zheng Y, Yang D, Gao B, Huang S, Tang Y, Wa Q, et al. A DNA-inspired injectable adhesive hydrogel with dual nitric oxide donors to promote angiogenesis for enhanced wound healing. Acta Biomater. 2024; 176: 128-43. https://doi.org/10.1016/j.actbio.2024.01.026.

[123] Zhang P, Li Y, Tang Y, Shen H, Li J, Yi Z, et al. Copper-based metal-organic framework as a controllable nitric oxide-releasing vehicle for enhanced diabetic wound healing. ACS Appl Mater Interfaces. 2020; 12: 18319-31. https://doi.org/10.1021/acsami.0c01792.

[124] Yao S, Wang Y, Chi J, Yu Y, Zhao Y, Luo Y, et al. Porous MOF microneedle Array patch with Photothermal responsive nitric oxide delivery for wound healing. Adv Sci Weinh Baden-Wurtt Ger. 2022; 9: e2103449. https://doi.org/10.1002/advs.202103449.

[125] Xie J, Liu G, Chen R, Wang D, Mai H, Zhong Q, et al. NIR-activated electrospun nanodetonator dressing enhances infected diabetic wound healing with combined photothermal and nitric oxide-based gas therapy. J Nanobiotechnology. 2024; 22: 232. https://doi.org/10.1186/s12951-024-02474-9.

[126] He C, Bi S, Zhang R, Chen C, Liu R, Zhao X, et al. A hyaluronic acid hydrogel as a mild photothermal antibacterial, antioxidant, and nitric oxide release platform for diabetic wound healing. J Control Release. 2024; 370: 543-55. https://doi.org/10.1016/j.jconrel.2024.05.011.

[127] Zhou X, Zhao B, Wang L, Yang L, Chen H, Chen W, et al. A glucose-responsive nitric oxide release hydrogel for infected diabetic wounds treatment. J Control Release. 2023; 359: 147-60. https://doi.org/10.1016/j.jconrel.2023.05.047.

[128] Chen HH, Fu FS, Chen QW, Zhang Y, Zhang XZ Two-pronged microbe delivery of nitric oxide and oxygen for diabetic wound healing. Nano Lett. 2023; 23: 5595-602. https://doi.org/10.1021/acs.nanolett.3c01023.

[129] Li Y, Fu R, Duan Z, Zhu C, Fan D Artificial nonenzymatic antioxidant MXene Nanosheet-anchored injectable hydrogel as a mild Photothermal-controlled oxygen release platform for diabetic wound healing. ACS Nano. 2022; 16: 7486-502. https://doi.org/10.1021/acsnano.1c10575.

[130] Zhao E, Xiao T, Tan Y, Zhou X, Li Y, Wang X, et al. Separable microneedles with photosynthesis-driven oxygen manufactory for diabetic wound healing. ACS Appl Mater Interfaces. 2023; 15: 7725-34. https://doi.org/10.1021/acsami.2c18809.

[131] Ullah A, Mamun AA, Zaidi MB, Roome T, Hasan A A calcium peroxide incorporated oxygen releasing chitosan-PVA patch for diabetic wound healing. Biomed Pharmacother Biomedecine Pharmacother. 2023; 165: 115156. https://doi.org/10.1016/j.biopha.2023.115156.

[132] Zhou Y, Jiang Y, Cai J, Wang J, Li S, Wang M, et al. A core/shell nanogenerator achieving pH-responsive nitric oxide release for treatment of infected diabetic wounds. Nanoscale. 2022; 14: 14984-96. https://doi.org/10.1039/D2NR03704A.

[133] Li Q, Dong M, Han Q, Zhang Y, Yang D, Wei D, et al. Enhancing diabetic wound healing with a pH-responsive nanozyme hydrogel featuring multi-enzyme-like activities and oxygen self-supply. J Control Release Off J Control Release Soc. 2024; 365: 905-18. https://doi.org/10.1016/j.jconrel.2023.12.015.

[134] Feng Y, Su L, Zhang Z, Chen Y, Younis MR, Chen D, et al. pH-responsive wound dressing based on biodegradable CuP Nanozymes for treating infected and diabetic wounds. ACS Appl Mater Interfaces. 2024; 16: 95-110. https://doi.org/10.1021/acsami.3c12997.

[135] Wang W, Lu K, Yu C, Huang Q, Du YZ Nano-drug delivery systems in wound treatment and skin regeneration. J Nanobiotechnology. 2019; 17: 82. https://doi.org/10.1186/s12951-019-0514-y.

[136] Hu L, Wang J, Zhou X, Xiong Z, Zhao J, Yu R, et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 2016; 6: 32993. https://doi.org/10.1038/srep32993.

[137] Johnson J, Law SQK, Shojaee M, Hall AS, Bhuiyan S, Lim MBL, et al. First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing. J Extracell Vesicles. 2023; 12: e12332. https://doi.org/10.1002/jev2.12332.

[138] Saeed S, Martins-Green M. Animal models for the study of acute cutaneous wound healing. Wound Repair Regen. 2023; 31: 6-16. https://doi.org/10.1111/wrr.13051.

[139] Gordillo GM, Bernatchez SF, Diegelmann R, Di Pietro LA, Eriksson E, Hinz B, et al. Preclinical models of wound healing: is Man the model? Proceedings of the wound healing society symposium.Adv Wound Care. 2013; 2: 1-4. https://doi.org/10.1089/wound.2012.0367.

[140] Kua JEH, Siow CW, Lim WK, Masilamani J, Tjin MS, Yeong J, et al. Human umbilical cord lining-derived epithelial cells: a potential source of non-native epithelial cells that accelerate healing in a porcine cutaneous wound model. Int J Mol Sci. 2022; 23: 8918. https://doi.org/10.3390/ijms23168918.

[141] Ren S, Guo S, Yang L, Wang C Effect of composite biodegradable biomaterials on wound healing in diabetes. Front Bioeng Biotechnol. 2022; 10: 1060026. https://doi.org/10.3389/fbioe.2022.1060026.

[142] Al-Masawa ME, Alshawsh MA, Ng CY, Ng AMH, Foo JB, Vijakumaran U, et al. Efficacy and safety of small extracellular vesicle interventions in wound healing and skin regeneration: a systematic review and meta-analysis of animal studies. Theranostics. 2022; 12: 6455-508. https://doi.org/10.7150/thno.73436.

[143] Guo L, Xiao D, Xing H, Yang G, Yang X Engineered exosomes as a prospective therapy for diabetic foot ulcers. Burns Trauma. 2024; 12: tkae023. https://doi.org/10.1093/burnst/tkae023.

[144] Cheng P, Xie X, Hu L, Zhou W, Mi B, Xiong Y, et al. Hypoxia endothelial cells-derived exosomes facilitate diabetic wound healing through improving endothelial cell function and promoting M2 macrophages polarization. Bioact Mater. 2024; 33: 157-73. https://doi.org/10.1016/j.bioactmat.2023.10.020.

[145] Wang J, Wu H, Peng Y, Zhao Y, Qin Y, Zhang Y, et al. Hypoxia adipose stem cell-derived exosomes promote high-quality healing of diabetic wound involves activation of PI3K/Akt pathways. J Nanobiotechnology. 2021; 19: 202. https://doi.org/10.1186/s12951-021-00942-0.

[146] Shi R, Jin Y, Hu W, Lian W, Cao C, Han S, et al. Exosomes derived from mmu_circ_0000250-modified adipose-derived mesenchymal stem cells promote wound healing in diabetic mice by inducing miR-128-3p/SIRT1-mediated autophagy. Am J Physiol-Cell Physiol. 2020; 318: C848-56. https://doi.org/10.1152/ajpcell.00041.2020.

[147] Liu W, Yu M, Xie D, Wang L, Ye C, Zhu Q, et al. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020; 11: 259. https://doi.org/10.1186/s13287-020-01756-x.

[148] Hu Y, Tao R, Chen L, Xiong Y, Xue H, Hu L, et al. Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis. J Nanobiotechnology. 2021; 19: 150. https://doi.org/10.1186/s12951-021-00894-5.

[149] Yu M, Liu W, Li J, Lu J, Lu H, Jia W, et al. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res Ther. 2020; 11: 350. https://doi.org/10.1186/s13287-020-01824-2.

[150] Lu W, Du X, Zou S, Fang Q, Wu M, Li H, et al. IFN-γ enhances the therapeutic efficacy of MSCs-derived exosome via miR-126-3p in diabetic wound healing by targeting SPRED1. J Diabetes. 2024; 16: e13465. https://doi.org/10.1111/1753-0407.13465.

[151] Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J, et al. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015; 13: 308. https://doi.org/10.1186/s12967-015-0642-6.

[152] Li Q, Hu W, Huang Q, Yang J, Li B, Ma K, et al. MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1. Signal Transduct Target Ther. 2023; 8: 62. https://doi.org/10.1038/s41392-022-01263-w.

[153] Sun B, Wu F, Wang X, Song Q, Ye Z, Mohammadniaei M, et al. An optimally designed engineering exosome-reductive COF integrated Nanoagent for synergistically enhanced diabetic fester wound healing. Small. 2022; 18: e2200895. https://doi.org/10.1002/smll.202200895.

[154] Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X Current strategies for exosome cargo loading and targeting delivery. Cells. 2023; 12: 1416. https://doi.org/10.3390/cells12101416.

[155] Zhang X, Huang J, Zhao J, Li L, Miao F, Zhang T, et al. Exosome-mimetic vesicles derived from fibroblasts carrying matrine for wound healing. Burns Trauma. 2024; 12: tkae015. https://doi.org/10.1093/burnst/tkae015.

[156] Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing. Mol Pharm. 2020; 17: 1723-33. https://doi.org/10.1021/acs.molpharmaceut.0c00177.

[157] Zhou X, Ye C, Jiang L, Zhu X, Zhou F, Xia M, et al. The bone mesenchymal stem cell-derived exosomal miR-146a-5p promotes diabetic wound healing in mice via macrophage M1/M2 polarization. Mol Cell Endocrinol. 2024; 579: 112089. https://doi.org/10.1016/j.mce.2023.112089.

[158] Huang J, Yu M, Yin W, Liang B, Li A, Li J, et al. Development of a novel RNAi therapy: engineered miR-31 exosomes promoted the healing of diabetic wounds. Bioact Mater. 2021; 6: 2841-53. https://doi.org/10.1016/j.bioactmat.2021.02.007.

[159] Zhao X, Fu L, Zou H, He Y, Pan Y, Ye L, et al. Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair. J Nanobiotechnology. 2023; 21: 176. https://doi.org/10.1186/s12951-023-01886-3.

[160] Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013; 2: 20360. https://doi.org/10.3402/jev.v2i0.20360.

[161] Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018; 7: 1535750. https://doi.org/10.1080/20013078.2018.1535750.

[162] Rani S, Ryan AE, Griffin MD, Ritter T Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther J Am Soc Gene Ther. 2015; 23: 812-23. https://doi.org/10.1038/mt.2015.44.